COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort
J Clin Immunol
.
2022 May;42(4):728-731.
doi: 10.1007/s10875-022-01223-7.
Epub 2022 Feb 11.
Authors
Mark J Ponsford
1
2
,
Kimberly Evans
1
,
Emily M Carne
1
,
Stephen Jolles
3
;
Immunodeficiency Centre for Wales and Division of Population Medicine
Collaborators
Immunodeficiency Centre for Wales and Division of Population Medicine
:
Kathryn Bramhall
,
Leanne Grant
,
Frances McGuire
,
Anthony Matthews
,
Rachel Bradley
,
Sonali Wijetilleka
,
Alison Pritchard
,
Colin R Price
,
Daniel Farewell
,
Richard Cousins
,
Tariq El-Shanawany
Affiliations
1
Immunodeficiency Centre for Wales, University Hospital of Wales, Heath Park, Cardiff, UK.
2
Institute of Infection & Immunity, Henry Wellcome Building, School of Medicine, Cardiff University, Heath Park, Cardiff, UK.
3
Immunodeficiency Centre for Wales, University Hospital of Wales, Heath Park, Cardiff, UK. jollessr@cardiff.ac.uk.
PMID:
35149962
PMCID:
PMC8853337
DOI:
10.1007/s10875-022-01223-7
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Cohort Studies
Humans
Immunologic Deficiency Syndromes* / therapy
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines
Grants and funding
WT_/Wellcome Trust/United Kingdom